Colorcon acquires French pharmaceutical excipient firm NP Pharm

28 April 2010

USA-based Colorcon says that is has acquired the full-service French pharmaceutical excipient company, NP Pharm, a division of Ethypharm, aiming to expand its  global excipient product offerings in the pharmaceutical and nutritional markets.

The addition of NP Pharm Suglets sugar spheres complements Colorcon's SureSpheres sugar spheres product line and barrier membrane systems for multiparticulates. Colorcon will now have two production facilities for sugar spheres offering critical business continuity planning for their customer base, the firm notes. Ethisperes microcrystalline cellulose pellets, Nptab neutral pellets for direct compression, and other excipient products are also added to the Colorcon product portfolio as a result of this acquisition.

The headquarters and main production facilities of NP Pharm, located in Bazainville, France, will become an integral part of the Colorcon network of manufacturing sites.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical